Development and Optimization of a Nanophytosomes-Based Thermogel as a Topical Anti-Psoriatic for Increased Solubility and Bioavailability

Abstract

Herbal extracts often demonstrate promising in vitro activity but limited in vivo efficacy due to poor solubility, permeability, and stability. Phytosomal delivery systems offer a strategy to increase the transdermal delivery and bioavailability. This study aimed to develop and optimize a Leucas aspera phytosomal thermogel for improved topical treatment of psoriasis. Phytosomes were-prepared from phospholipid complexes and optimized via a Box–Behnken design. The optimized formulation was evaluated for vesicle size, zeta potential, entrapment efficiency (EE), in vitro drug release, and skin deposition. Anti-psoriatic efficacy was assessed in an imiquimod induced psoriasis mouse model through PASI scoring, ear thickness measurement, organ index analysis, transepidermal water loss and hydration studies, and histopathology. The optimized PHY gel exhibited a particle size of 92.23 ± 9.1 nm, zeta potential of −32.45 ± 0.43 mV, EE of 89.1 ± 4.6%, and cumulative drug release of 94.5 ± 1.3%. Skin deposition was significantly greater (82.61 ± 1.86%) than that of the unmodified extract gel. In vivo, the phytosome gel reduced imiquimod induced psoriasis severity, demonstrating efficacy comparable to that of the reference formulation. Overall, the Leucas aspera phytosome gel significantly improved dermal delivery and therapeutic efficacy, highlighting phytosomal systems as a promising platform for topical psoriasis therapy.

Keywords

Box–Behnken design / imiquimod / Leucas aspera / phytosomes / psoriasis / Zyclara

References

[1] S. I. Alkhamaiseh and M. Aljofan, “Prevalence of Use and Reported Side Effects of Herbal Medicine Among Adults in Saudi Arabia,” Complementary Therapies in Medicine 48 (2020): 102255.

[2] I. S. Flores, B. C. B. Martinelli, and L. M. Lião, “High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) as a Tool in the Determination of Biomarkers of Passiflora-Based Herbal Medicines,” Fitoterapia 142 (2020): 104500.

[3] K. Yang, X. M. Long, J. J. Cao, et al., “An Analytical Strategy to Explore the Multicomponent Pharmacokinetics of Herbal Medicine Independently of Standards: Application in Gelsemium Elegans Extracts,” Journal of Pharmaceutical and Biomedical Analysis 176 (2019): 112833.

[4] R. K. Harwansh, R. Deshmukh, and M. A. Rahman, “Nanoemulsion: Promising Nanocarrier System for Delivery of Herbal Bioactives,” Journal of Drug Delivery Science and Technology 51 (2019): 224–233.

[5] P. Rathee, A. Kamboj, and S. Sidhu, “Optimization and Development of Nisoldipine Nano-Bioenhancers by Novel Orthogonal Array (L27 Array),” International Journal of Biological Macromolecules 86 (2016): 556–561.

[6] C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez, “Polyphenols: Food Sources and Bioavailability,” American Journal of Clinical Nutrition 79, no. 5 (2004): 727–747.

[7] H. Bhatia and D. Ahuja, “Novel Plumbago Indica L. Extract Herbosomes: Development AND Optimization Using Experimental Design,” Journal of Population Therapeutics and Clinical Pharmacology 29, no. 4 (2022): 1559–1568, https://doi.org/10.53555/jptcp.v29i04.4626.

[8] G. Joshi, A. Tiwari, and P. Upadhyay, “Development and Characterization of Herbosomes Complex,” Indo American Journal of Pharmaceutical Research 10, no. 6 (2020): 736–745.

[9] S. Soman, “Phytosomes - A Novel Approach for Herbal Drug Delivery,” Journal of Animal Research 10, no. 4 (2020): 479–485.

[10] H. T. H. Vu, S. M. Hook, S. D. Siqueira, A. Müllertz, T. Rades, and A. McDowell, “Are Phytosomes a Superior Nanodelivery System for the Antioxidant Rutin?,” International Journal of Pharmaceutics 548, no. 1 (2018): 82–91.

[11] D. R. Telange, A. T. Patil, A. M. Pethe, H. Fegade, S. Anand, and V. S. Dave, “Formulation and Characterization of An Apigenin-Phospholipid Phytosome (APLC) for Improved Solubility, In Vivo Bioavailability, and Antioxidant Potential,” European Journal of Pharmaceutical Sciences 108 (2017): 36–49.

[12] M. K. Das and B. Kalita, “Design and Evaluation of Phyto-Phospholipid Complexes (Phytosomes) of Rutin for Transdermal Application,” Journal of Applied Pharmaceutical Science 4, no. 10 (2014): 51–57.

[13] M. Lu, Q. Qiu, X. Luo, et al., “Phyto-Phospholipid Complexes (Phytosomes): A Novel Strategy to Improve the Bioavailability of Active Constituents,” Asian Journal of Pharmaceutical Sciences 14, no. 3 (2019): 265–274.

[14] A. Shakeri and A. Sahebkar, “Opinion Paper: Phytosome: A Fatty Solution for Efficient Formulation of Phytopharmaceuticals,” Recent Patents on Drug Delivery & Formulation 10, no. 1 (2016): 7–10.

[15] J. Khan, A. Alexander, Ajazuddin, S. Saraf, and S. Saraf, “Recent Advances and Future Prospects of Phyto-Phospholipid Complexation Technique for Improving Pharmacokinetic Profile of Plant Actives,” Journal of Controlled Release 168, no. 1 (2013): 50–60.

[16] E. Hammam, J. Basahi, I. Ismail, I. Hassan, and T. Almeelbi, “The Role of Hydrogen Bonding in the Fluorescence Quenching of 2,6-bis((E)-2-(benzoxazol-2-yl)vinyl)naphthalene (Bbvn) in Methanol,” Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 173 (2017): 681–686.

[17] J. Zhao, P. Song, Y. Cui, et al., “Effects of Hydrogen Bond on 2-aminopyridine and Its Derivatives Complexes in Methanol Solvent,” Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy 131 (2014): 282–287.

[18] Y. Elnaggar and Abdallah Freag, “Lyophilized Phytosomal Nanocarriers as Platforms for Enhanced Diosmin Delivery: Optimization and Ex Vivo Permeation,” International Journal of Nanomedicine 8 (2013): 2385–2397, https://doi.org/10.2147/IJN.S45231.

[19] R. P. Singh, H. V. Gangadharappa, and K. Mruthunjaya, “Phytosome Complexed With Chitosan for Gingerol Delivery in the Treatment of Respiratory Infection: In Vitro and In Vivo Evaluation,” European Journal of Pharmaceutical Sciences 122 (2018): 214–229.

[20] P. Ju Ho, J. Jun Sung, K. Ki Cheon, and H. Jin Tae, “Anti-Inflammatory Effect of Centella Asiatica Phytosome in a Mouse Model of Phthalic Anhydride-Induced Atopic Dermatitis,” Phytomedicine 43 (2018): 110–119.

[21] S. Surini, H. Mubarak, and D. Ramadon, “Cosmetic Serum Containing Grape (Vitis Vinifera L.) Seed Extract Phytosome: Formulation and In Vitro Penetration Study,” Journal of Young Pharmacists 10, no. 2s (2018): S51–S55.

[22] X. Huang, N. Xu, Z. Liu, H. Li, H. Lu, and J. Li, “Chemical Composition of Achillea millefolium L. and Their Anti-Inflammatory Activity,” Chemistry & Biodiversity 21, no. 8 (2024): e202400946.

[23] J. Zaringhalam, “Achillea Santolina Reduces Serum interlukin-6 Level and Hyperalgesia During Complete Freund's Adjuvant-Induced Inflammation in Male Wistar Rats,” Journal of Chinese Integrative Medicine 8, no. 12 (2010): 1180–1189.

[24] M. N. Qureshi, G. Stecher, and G. K. Bonn, “Quantification of Polyphenolic Compounds and Flavonoids in Achillea Millefolium and Equisetum Arvense,” Pakistan Journal of Pharmaceutical Sciences 29, no. 5 (2016): 1519–1523.

[25] W. Jesionek, B. Majer-Dziedzic, and I. M. Choma, “Separation, Identification, and Investigation of Antioxidant Ability of Plant Extract Components Using TLC, LC–MS, AND TLC–DPPH•,” Journal of Liquid Chromatography & Related Technologies 38, no. 11 (2015): 1147–1153.

[26] D. Nashaat, M. Elsabahy, K. M. A. Hassanein, G. A. El-Gindy, and E. H. Ibrahim, “Development and In Vivo Evaluation of Therapeutic Phytosomes for Alleviation of Rheumatoid Arthritis,” International Journal of Pharmaceutics 644 (2023): 123332.

[27] S. S. Raghav, B. Kumar, N. K. Sethiya, and S. Pahwa, “Development and Optimization of Kaempferol Loaded Ethosomes Using Box–Behnken Statistical Design: In Vitro and Ex-Vivo Assessments,” Journal of Biomedical Materials Research, Part B: Applied Biomaterials 112, no. 3 (2024): e35394.

[28] V. Mane, S. Killedar, H. More, S. Nadaf, S. Salunkhe, and H. Tare, “Novel Phytosomal Formulation of Emblica officinalis Extracts with Its In Vivo Nootropic Potential in Rats: Optimization and Development by Box-Behnken Design,” Journal of Chemistry 2024 (2024): 1–19.

[29] V. Metkari, R. Shah, N. Salunkhe, and S. Gurav, “QBD Approach for the Design, Optimization, Development, and Characterization of Naringenin-Loaded Phytosomes to Enhance Solubility and Oral Bioavailability,” Journal of Pharmaceutical Innovation 18, no. 4 (2023): 2083–2097.

[30] L. X. Yu, G. Amidon, M. A. Khan, et al., “Understanding Pharmaceutical Quality by Design,” AAPS Journal 16, no. 4 (2014): 771–783.

[31] V. Dubey, D. Mishra, T. Dutta, M. Nahar, D. K. Saraf, and N. K. Jain, “Dermal and Transdermal Delivery of An Anti-Psoriatic Agent via Ethanolic Liposomes,” Journal of Controlled Release 123, no. 2 (2007): 148–154.

[32] A. Husain, P. Kushwaha, A. Kapoor, and P. Singh, “Exploring the Therapeutic Potential of Lipid Nanocarriers in Psoriasis Management: Advances and Applications,” AAPS PharmSciTech 26, no. 7 (2025): 195.

[33] A. K. Chettupalli, M. Ananthula, P. R. Amarachinta, V. Bakshi, and V. K. Yata, “Design, Formulation, In-Vitro and Ex-Vivo Evaluation of Atazanavir Loaded Cubosomal Gel,” Biointerface Research in Applied Chemistry 11, no. 4 (2020): 12037–12054.

[34] A. K. Chettupalli, R. R. Amara, P. R. Amarachinta, R. M. Manda, B. S. R. Garige, and V. K. Yata, “Formulation and Evaluation of Poly Herbal Liqui-Solid Compact for Its Anti-Inflammatory Effect,” Biointerface Research in Applied Chemistry 12, no. 3 (2021): 3883–3899.

[35] C. Chi, C. Zhang, Y. Liu, H. Nie, J. Zhou, and Y. Ding, “Phytosome-Nanosuspensions for Silybin-Phospholipid Complex With Increased Bioavailability and Hepatoprotection Efficacy,” European Journal of Pharmaceutical Sciences 144 (2020): 105212.

[36] A. Babazadeh, B. Ghanbarzadeh, and H. Hamishehkar, “Phosphatidylcholine-Rutin Complex as a Potential Nanocarrier for Food Applications,” Journal of Functional Foods 33 (2017): 134–141.

[37] D. Li, Z. Wei, J. Sun, and C. Xue, “Tremella Polysaccharides-Coated Zein Nanoparticles for Enhancing Stability and Bioaccessibility of Curcumin,” Current Research in Food Science 5 (2022): 611–618.

[38] F. Yu, M. Ao, X. Zheng, et al., “PEG–Lipid–PLGA Hybrid Nanoparticles Loaded With Berberine–Phospholipid Complex to Facilitate the Oral Delivery Efficiency,” Drug Delivery 24, no. 1 (2017): 825–833.

[39] W. Maryana, A. Rahma, D. Mudhakir, and H. Rachmawati, “Phytosome Containing Silymarin for Oral Administration: Formulation and Physical Evaluation,” Journal of Biomimetics, Biomaterials and Biomedical Engineering 25 (2015): 54–65.

[40] T. Wu, X. Li, W. Wei, and Y. Wu, “Research Progress of Microneedle Drug Delivery System in the Treatment of Autoimmune Diseases,” Journal of Drug Targeting 34, no. 2 (2025): 185–201, https://doi.org/10.1080/1061186X.2025.2546477.

[41] R. M. Aman, R. A. Zaghloul, W. M. Elsaed, and I. I. A. Hashim, “In Vitro–In Vivo Assessments of Apocynin-Hybrid Nanoparticle-Based Gel as An Effective Nanophytomedicine for Treatment of Rheumatoid Arthritis,” Drug Delivery and Translational Research 13, no. 11 (2023): 2903–2929.

[42] N. Kumar, R. Goel, M. N. Ansari, et al., “Formulation of Phytosomes Containing Rubia cordifolia Extract for Neuropathic Pain: In Vitro and In Vivo Evaluation,” ACS Omega 9, no. 23 (2024): 25381–25389.

[43] M. Deleanu, L. Toma, G. M. Sanda, et al., “Formulation of Phytosomes With Extracts of Ginger Rhizomes and Rosehips With Improved Bioavailability, Antioxidant and Anti-Inflammatory Effects In Vivo,” Pharmaceutics 15, no. 4 (2023): 1066.

[44] A. Kulawik-Pióro and M. Miastkowska, “Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review,” International Journal of Molecular Sciences 22, no. 10 (2021): 5124.

[45] D. Ilyas, A. Javed, A. Tariq, et al., “A Promising Topical Therapy for Treatment of Psoriasis: Acitretin Encapsulated Novel Transethosomal Gel,” Journal of Drug Delivery Science and Technology 105 (2025): 106606.

[46] V. L. Singleton and J. A. Rossi, “Colorimetry of Total Phenolics With Phosphomolybdic-Phosphotungstic Acid Reagents,” American Journal of Enology and Viticulture 16, no. 3 (1965): 144–158.

[47] J. Zhishen, T. Mengcheng, and W. Jianming, “The Determination of Flavonoid Contents in Mulberry and Their Scavenging Effects on Superoxide Radicals,” Food Chemistry 64, no. 4 (1999): 555–559.

[48] Q. U. Ain, H. Khan, M. S. Mubarak, and A. Pervaiz, “Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments,” Frontiers in Pharmacology 7 (2016): 292.

[49] M. Ajanal, M. Gundkalle, and S. Nayak, “Estimation of Total Alkaloid in Chitrakadivati by UV-Spectrophotometer,” Ancient Science of Life 31, no. 4 (2012): 198–201.

[50] F. Yu, Y. Li, Q. Chen, et al., “Monodisperse Microparticles Loaded With the Self-Assembled Berberine-Phospholipid Complex-Based Phytosomes for Improving Oral Bioavailability and Enhancing Hypoglycemic Efficiency,” European Journal of Pharmaceutics and Biopharmaceutics 103 (2016): 136–148.

[51] M. S. Freag, W. M. Saleh, and O. Y. Abdallah, “Laminated Chitosan-Based Composite Sponges for Transmucosal Delivery of Novel Protamine-Decorated Tripterine Phytosomes: Ex-Vivo Mucopenetration and In-Vivo Pharmacokinetic Assessments,” Carbohydrate Polymers 188 (2018): 108–120.

[52] B. Singh, M. Dahiya, V. Saharan, and N. Ahuja, “Optimizing Drug Delivery Systems Using Systematic “Design of Experiments.” Part Ii: Retrospect and Prospects,” Critical Reviews in Therapeutic Drug Carrier Systems 22, no. 3 (2005): 215–294.

[53] Q. Tan, S. Liu, X. Chen, et al., “Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral Bioavailability,” AAPS PharmSciTech 13, no. 2 (2012): 534–547.

[54] B. Singh, R. Kapil, M. Nandi, and N. Ahuja, “Developing Oral Drug Delivery Systems Using Formulation by Design: Vital Precepts, Retrospect and Prospects,” Expert Opinion on Drug Delivery 8, no. 10 (2011): 1341–1360.

[55] P. A. Ittadwar and P. K. Puranik, “Novel Umbelliferone Phytosomes: Development AND Optimization Using Experimental Design Approach and Evaluation of Photo-Protective and Antioxidant Activity,” International Journal of Pharmacy and Pharmaceutical Sciences 9, no. 1 (2016): 218.

[56] R. Shukla, G. Tiwari, R. Tiwari, and A. K. Rai, “Formulation and Evaluation of the Topical Ethosomal Gel of Melatonin to Prevent UV Radiation,” Journal of Cosmetic Dermatology 19, no. 8 (2020): 2093–2104.

[57] A. Semalty, M. Semalty, D. Singh, and M. S. M. Rawat, “Phyto-Phospholipid Complex of Catechin in Value Added Herbal Drug Delivery,” Journal of Inclusion Phenomena and Macrocyclic Chemistry 73, no. 1–4 (2012): 377–386.

[58] A. K. Chettupalli, S. P. N. Bukke, S. A. Rahaman, et al., “Ritonavir Loaded Solid Lipid Nanoparticles for Oral Drug Delivery and Bioavailability Enhancement,” Discover Applied Sciences 7, no. 1 (2025): 58.

[59] L. H. Sameina, S. Idamakantia, A. K. Chettupalli, R. R. Velamala, and M. O. Ezzat, “Design of Mesalamine Loaded Micro-Particles: Preparation, In Vitro and In-Vivo Characterization,” Mater Today Proc. (2023): S2214785323039251, https://doi.org/10.1016/j.matpr.2023.07.063.

[60] A. K. Chettupalli, S. Ajmera, M. Kuchukuntla, V. Palanivel, and S. Katta, “Design Formulation of Nanospanlastic Novel Carriers as a Promisingapproach to Enhanced Bioavailability in Intranasal Drug Delivery Forsinusitis: Statistical Optimization and In Vitro and In Vivo Characterization,” Current Nanomedicine 14, no. 3 (2024): 266–288.

[61] A. K. Chettupalli, S. P. N. Bukke, J. Vardhan, et al., “Polyherbal Formulations and Phytosome-Based Delivery in Diabetic Wound Healing: An Integrative Review,” Journal of Biomaterials Science, Polymer Edition (2025): 1–28.

[62] P. R. Amarachinta, G. Sharma, N. Samed, A. K. Chettupalli, M. Alle, and J. C. Kim, “Central Composite Design for the Development of Carvedilol-Loaded Transdermal Ethosomal Hydrogel for Extended and Enhanced Anti-Hypertensive Effect,” Journal of Nanobiotechnology 19, no. 1 (2021): 100.

[63] A. Jain, R. Verma, P. Mehta, et al., “Formulation and Evaluation of Phytosomes Loaded With Pithecellobium Bijeninum Leaf Extract,” Current Research in Pharmaceutical Sciences 13, no. 3 (2023): 151–156.

[64] S. Sharma and A. Sahu, “Development, Characterization, and Evaluation of Hepatoprotective Effect of Abutilon Indicum and Piper Longum Phytosomes,” Pharmacognosy Research 8, no. 1 (2016): 29–36.

[65] U. Fahmy, S. Badr-Eldin, O. Ahmed, et al., “Retracted: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation,” Pharmaceutics 12, no. 6 (2020): 485.

[66] N. B. Aksu, V. Yozgatlı, M. E. Okur, Ş. Ayla, A. Yoltaş, and N. Üstündağ Okur, “Preparation and Evaluation of QbD Based Fusidic Acid Loaded in Situ Gel Formulations for Burn Wound Treatment,” Journal of Drug Delivery Science and Technology 52 (2019): 110–121.

[67] H. Nsairat, D. Khater, F. Odeh, et al., “Phytosomes: a modernistic approach to the delivery of herbal drugs,” in Advanced and Modern Approaches for Drug Delivery, ed. A. K. Nayak, M. S. Hasnain, B. Laha, and S. Maiti (Elsevier, 2023), 301–355, https://doi.org/10.1016/B978-0-323-91668-4.00029-0.

[68] D. S. Malik and G. Kaur, “Nanostructured Gel for Topical Delivery of Azelaic Acid: Designing, Characterization, and In-Vitro Evaluation,” Journal of Drug Delivery Science and Technology 47 (2018): 123–136.

[69] C. Lu, M. Liu, H. Fu, et al., “Novel Thermosensitive in Situ Gel Based on Poloxamer for Uterus Delivery,” European Journal of Pharmaceutical Sciences 77 (2015): 24–28.

[70] J. Mariam Joshua, A. Anilkumar, V. Cu, D. T Vasudevan, and S. A Surendran, “Formulation and Evaluation of Antiaging Phytosomal Gel,” Asian Journal of Pharmaceutical and Clinical Research 11, no. 3 (2018): 409.

[71] L. Van Der Fits, S. Mourits, J. S. A. Voerman, et al., “Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis,” Journal of Immunology 182, no. 9 (2009): 5836–5845.

[72] S. Y. Chuang, C. H. Lin, C. T. Sung, and J. Y. Fang, “Murine Models of Psoriasis and Their Usefulness for Drug Discovery,” Expert Opinion on Drug Discovery 13, no. 6 (2018): 551–562.

[73] R. Corrêa-Oliveira, J. L. Fachi, A. Vieira, F. T. Sato, and M. A. R. Vinolo, “Regulation of Immune Cell Function by Short-Chain Fatty Acids,” Clinical & Translational Immunology 5, no. 4 (2016): e73.

[74] Y. Sun, J. Zhang, R. Huo, et al., “Paeoniflorin Inhibits Skin Lesions in Imiquimod-Induced Psoriasis-Like Mice by Downregulating Inflammation,” International Immunopharmacology 24, no. 2 (2015): 392–399.

[75] K. Schaper, J. Dickhaut, L. Japtok, et al., “Sphingosine-1-phosphate Exhibits Anti-Proliferative and Anti-Inflammatory Effects in Mouse Models of Psoriasis,” Journal of Dermatological Science 71, no. 1 (2013): 29–36.

[76] N. Arora, K. Shah, and S. Pandey-Rai, “Inhibition of Imiquimod-Induced Psoriasis-Like Dermatitis in Mice by Herbal Extracts From Some Indian Medicinal Plants,” Protoplasma 253, no. 2 (2016): 503–515.

[77] R. R. Molls, V. Savransky, M. Liu, et al., “Keratinocyte-Derived Chemokine Is an Early Biomarker of Ischemic Acute Kidney Injury,” American Journal of Physiology-Renal Physiology 290, no. 5 (2006): F1187–F1193.

[78] P. R. Gore, C. P. Prajapati, U. B. Mahajan, et al., “Protective Effect of Thymoquinone Against Cyclophosphamide-Induced Hemorrhagic Cystitis Through Inhibiting DNA Damage and Upregulation of Nrf2 Expression,” International Journal of Biological Sciences 12, no. 8 (2016): 944–953.

[79] J. H. Han, J. Lee, S. J. Jeon, et al., “In Vitro and In Vivo Growth Inhibition of Prostate Cancer by the Small Molecule Imiquimod,” International Journal of Oncology 42, no. 6 (2013): 2087–2093.

[80] B. Y. Kim, J. W. Choi, B. R. Kim, and S. W. Youn, “Histopathological Findings Are Associated With the Clinical Types of Psoriasis but Not With the Corresponding Lesional Psoriasis Severity Index,” Annals of Dermatology 27, no. 1 (2015): 26.

[81] S. Biswas, P. K. Mukherjee, R. K. Harwansh, S. Bannerjee, and P. Bhattacharjee, “Enhanced Bioavailability and Hepatoprotectivity of Optimized Ursolic Acid–Phospholipid Complex,” Drug Development and Industrial Pharmacy 45, no. 6 (2019): 946–958.

[82] H. N. Mayrovitz, “Transepidermal Water Loss and Stratum Corneum Hydration in Forearm Versus Hand Palm,” Skin Research and Technology 29, no. 3 (2023): e13218.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm - Biomaterials and Applications published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).